63
Views
4
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Karyotype changes during long-term targeted therapy of chronic myeloid leukemia with imatinib

, , , , , , , , & show all
Pages 952-965 | Received 16 Oct 2008, Accepted 09 Feb 2009, Published online: 21 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lucy A. Godley. (2009) Deletion of the der(9q) in chronic myeloid leukemia: the controversy continues. Leukemia & Lymphoma 50:6, pages 871-872.
Read now

Articles from other publishers (3)

Zahraa A. Abdulrazaq, Mushtak T.S. Al-Ouqaili & Nabeel M. Talib. (2024) The impact of circulating 25-hydroxyvitamin D and vitamin D receptor variation on leukemia-lymphoma outcome: Molecular and cytogenetic study. Saudi Journal of Biological Sciences 31:1, pages 103882.
Crossref
Muhammad Asif, Mohammad Sarwar Jamal, Abdul Rehman Khan, Muhammad Imran Naseer, Abrar Hussain, Hani Choudhry, Arif Malik, Shahida Aziz Khan, Maged Mostafa Mahmoud, Ashraf Ali, Saima Iram, Kashif Kamran, Asim Iqbal, Zainularifeen Abduljaleel, Peter Natesan Pushparaj & Mahmood Rasool. (2016) A Novel Four-Way Complex Variant Translocation Involving Chromosome 46,XY,t(4;9;19;22)(q25:q34;p13.3;q11.2) in a Chronic Myeloid Leukemia Patient. Frontiers in Oncology 6.
Crossref
Woo-Seong KimGeon ParkSook-Jin JangDae-Soo MoonSeong-Ho Kang. (2015) A Novel Four-Way Translocation t(5;9;22;18)(q31;q34;q11.2;q21) in a Patient with Chronic Myelogenous Leukemia. Laboratory Medicine Online 5:2, pages 101.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.